[go: up one dir, main page]

NO984835L - Autoantigen og proteiner strukturelt relatert til dette for anvendelse i immunoterapi av autoimmune sykdommer - Google Patents

Autoantigen og proteiner strukturelt relatert til dette for anvendelse i immunoterapi av autoimmune sykdommer

Info

Publication number
NO984835L
NO984835L NO984835A NO984835A NO984835L NO 984835 L NO984835 L NO 984835L NO 984835 A NO984835 A NO 984835A NO 984835 A NO984835 A NO 984835A NO 984835 L NO984835 L NO 984835L
Authority
NO
Norway
Prior art keywords
autoantigen
immunotherapy
autoimmune diseases
structurally related
proteins structurally
Prior art date
Application number
NO984835A
Other languages
English (en)
Norwegian (no)
Other versions
NO984835D0 (no
Inventor
Anna Maria Helena Boots
Gijsbertus Francisc Verheijden
Ebo Sybren Bos
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO984835D0 publication Critical patent/NO984835D0/no
Publication of NO984835L publication Critical patent/NO984835L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Environmental Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Animal Husbandry (AREA)
  • Biomedical Technology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
NO984835A 1996-04-18 1998-10-16 Autoantigen og proteiner strukturelt relatert til dette for anvendelse i immunoterapi av autoimmune sykdommer NO984835L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/634,493 US5843449A (en) 1996-03-25 1996-04-18 Proteins and novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
PCT/EP1997/001903 WO1997040149A1 (en) 1996-04-18 1997-04-15 Autoantigen and proteins structurally related thereto for use in immunotherapy of autoimmune diseases

Publications (2)

Publication Number Publication Date
NO984835D0 NO984835D0 (no) 1998-10-16
NO984835L true NO984835L (no) 1998-12-16

Family

ID=24544023

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984835A NO984835L (no) 1996-04-18 1998-10-16 Autoantigen og proteiner strukturelt relatert til dette for anvendelse i immunoterapi av autoimmune sykdommer

Country Status (16)

Country Link
US (1) US5843449A (pt)
EP (1) EP0904369A1 (pt)
JP (1) JP2000509265A (pt)
KR (1) KR20000005476A (pt)
CN (1) CN1216582A (pt)
AU (1) AU724547B2 (pt)
BR (1) BR9708714A (pt)
CA (1) CA2251584A1 (pt)
CZ (1) CZ333398A3 (pt)
HU (1) HU221348B1 (pt)
NO (1) NO984835L (pt)
NZ (1) NZ332311A (pt)
PL (1) PL187451B1 (pt)
RU (1) RU2189248C2 (pt)
TR (1) TR199802082T2 (pt)
WO (1) WO1997040149A1 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928928A (en) * 1995-06-07 1999-07-27 Universiteit Van Amsterdam Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
EP1100526A2 (en) * 1998-07-23 2001-05-23 Akzo Nobel N.V. USE OF HC gp-39 IN IMMUNE DISEASES
IL126447A (en) * 1998-10-04 2004-09-27 Vascular Biogenics Ltd An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
US20050197283A1 (en) * 1998-10-04 2005-09-08 Vascular Biogenics Ltd. Compositions containing beta 2-glycoprotein I for the prevention and/or treatment of vascular disease
US20020102581A1 (en) * 1999-02-19 2002-08-01 Hageman Gregory S. Diagnostics and therapeutics for ocular disorders
US7534605B2 (en) 1999-06-08 2009-05-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
US7011952B2 (en) 2000-02-22 2006-03-14 University Of Iowa Research Foundation Diagnostics and therapeutics for macular degeneration-related disorders
AU6110301A (en) * 2000-04-29 2001-11-12 Univ Iowa Res Found Diagnostics and therapeutics for macular degeneration-related disorders
CN1352087A (zh) * 2000-11-02 2002-06-05 上海博德基因开发有限公司 一种新的多肽——人糖蛋白42和编码这种多肽的多核苷酸
GB0105360D0 (en) * 2001-03-03 2001-04-18 Glaxo Group Ltd Chimaeric immunogens
US7265208B2 (en) 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
US8195187B2 (en) 2001-06-25 2012-06-05 Airvana Network Solutions, Inc. Radio network control
US8160020B2 (en) 2001-06-25 2012-04-17 Airvana Network Solutions, Inc. Radio network control
HUP0400659A3 (en) * 2001-07-24 2005-06-28 Zhu Zhou Woodbridge Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
EP1729805A4 (en) * 2004-02-25 2008-11-26 Medimmune Inc METHODS AND COMPOSITIONS RELATED TO CHITINASES AND CHITINASE-MOLECULARS AND MODULATION OF OSTEOCLASTS
US8099504B2 (en) 2005-06-24 2012-01-17 Airvana Network Solutions, Inc. Preserving sessions in a wireless network
WO2007027748A2 (en) * 2005-08-31 2007-03-08 Medimmune, Inc. C/clp antagonists and methods of use thereof
US7751835B2 (en) 2005-10-04 2010-07-06 Airvana, Inc. Non-circular paging areas
US8094630B2 (en) 2005-12-16 2012-01-10 Airvana Network Solutions, Inc. Radio frequency dragging prevention
US8619702B2 (en) 2005-12-16 2013-12-31 Ericsson Evdo Inc. Radio network control
US8145221B2 (en) 2005-12-16 2012-03-27 Airvana Network Solutions, Inc. Radio network communication
US8085696B2 (en) 2006-07-14 2011-12-27 Airvana Networks Solutions, Inc. Dynamic modification of route update protocols
US8843638B2 (en) 2007-12-13 2014-09-23 Ericsson Evdo Inc. Handing off active connections
PE20110225A1 (es) 2008-08-05 2011-04-05 Novartis Ag Composiciones y metodos para anticuerpos que se dirigen a la proteina de complemento c5
WO2015120130A1 (en) 2014-02-07 2015-08-13 Novartis Ag Impact of genetic factors on disease progression and response to anti-c5 antibody in geographic atrophy
EP3169343B1 (en) 2014-07-15 2020-03-25 Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. Isolated polypeptides of cd44 and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284623A (en) * 1979-11-09 1981-08-18 Beck Lee R Method of treating inflammation using bovine milk
JPS6323898A (ja) * 1986-07-16 1988-02-01 Dainippon Pharmaceut Co Ltd 新規ポリペプチド及びそれをコ−ドするｄｎａ並びにそれらの製法
CA2164498C (en) * 1993-07-09 2007-09-11 Paul A. Price Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
BR9507452A (pt) * 1994-04-08 1997-08-05 Brigham & Womens Hospital Composição farmacêutica uso de um polipeptídeo não-interferon uso de uma quantidade de um antígeno padronizado e uma quantidade de um polipeptídeo não-interferon e produto contendo (1) uma quantidade de um antígeno padronizado e (11) uma quantidade de um polipeptídeo não-interferon
IL115744A (en) * 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39

Also Published As

Publication number Publication date
AU724547B2 (en) 2000-09-28
US5843449A (en) 1998-12-01
TR199802082T2 (xx) 2000-09-21
PL187451B1 (pl) 2004-07-30
CZ333398A3 (cs) 1999-03-17
RU2189248C2 (ru) 2002-09-20
CN1216582A (zh) 1999-05-12
JP2000509265A (ja) 2000-07-25
EP0904369A1 (en) 1999-03-31
PL329350A1 (en) 1999-03-29
BR9708714A (pt) 1999-08-03
CA2251584A1 (en) 1997-10-30
HU221348B1 (en) 2002-09-28
KR20000005476A (ko) 2000-01-25
NZ332311A (en) 2000-05-26
AU2386997A (en) 1997-11-12
WO1997040149A1 (en) 1997-10-30
HUP9903378A2 (hu) 2000-02-28
HUP9903378A3 (en) 2001-01-29
NO984835D0 (no) 1998-10-16

Similar Documents

Publication Publication Date Title
NO984835D0 (no) Autoantigen og proteiner strukturelt relatert til dette for anvendelse i immunoterapi av autoimmune sykdommer
ATE393216T1 (de) Formulierungen vernetzter proteinkristalle und ihre verwendung als katalysatoren in organischen lösungsmitteln
DK0797431T3 (da) Aerosolformuleringer af peptider og proteiner
DK0948349T3 (da) In vitro-fremgangsmåder og anvendelse af farmaceutiske præparater til behandling af indre øre-hårceller
IS5405A (is) Prostaglandín gerandefni og notkun þeirra til að meðhöndla beintruflanir
NO972125L (no) Hemorroideblandinger og fremgangsmåte for anvendelse
GB9617021D0 (en) Novel peptides for treatment of inflammation and shock
DK535988A (da) Immunosuppressive peptider og anvendelsesmetoder
HUP9904237A3 (en) Expression of globin proteins in plants
AU4054697A (en) Mhc binding peptide oligomers and methods of use
HU910605D0 (en) Vectors and molecules for expressing zymogenous form of human c protein
DE69731400D1 (de) Proliferation humaner endokriner pankreaszellen in kultur
AU5605398A (en) Novel methods and compositions for treatment of autoimmune diseases
PL321161A1 (en) Novel mpnpclonal antibodies eacting as inhibitors in respect to phospholipase a2 og type ii and protein containing some of them
IL109262A0 (en) Cell free system for protein synthesis and use of chaperon proteins therein
EP0786001A4 (en) CHEMOKIN-LIKE PROTEINS AND THEIR USE
AU4236097A (en) Mhc peptides and methods of use
IL129024A0 (en) Use of proteins as agent against autoimmune diseases
IL126873A0 (en) Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors
NO991465L (no) FremgangsmÕter og preparater for lipidisering av hydrofile molekyler
NO980811D0 (no) Blanding av estere og anvendelse derav
AU7525796A (en) Novel inhibitors of peptide binding to mhc class ii proteins
NO20010355L (no) Nye peptider for anvendelse i immunterapi av autoimmune sykdommer
GB9602850D0 (en) Novel inhibitors of peptide binding to MHC class II proteins
GB9602976D0 (en) Novel inhibitors of peptide binding to mhc class II proteins

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application